GlassScriptPhysician profile
Samuel R Chacon
NPI 1215991856
$16,828.89
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,912 · 2020: $539 · 2021: $4,142 · 2022: $9,797 · 2023: $422 · 2024: $17.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238 · Education: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.25 |
| Education | $201.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,339.60 | 2019-2023 | Solyx Sis System |
| Caldera Medical, INC | $4,807.17 | 2019-2022 | |
| Intuitive Surgical, INC. | $1,233.70 | 2019 | |
| Astellas Pharma US INC | $651.56 | 2020-2023 | Veozah, Myrbetriq |
| Abbvie INC. | $488.30 | 2019-2022 | |
| Therapeuticsmd, INC. | $283.58 | 2019-2022 | |
| Pfizer INC. | $244.57 | 2019-2024 | |
| Myovant Sciences INC. | $145.82 | 2021-2022 | |
| Urovant Sciences INC | $102.27 | 2021-2022 | |
| Allergan, INC. | $61.41 | 2019 | |
| Amag Pharmaceuticals, INC. | $55.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.20 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $49.38 | 2023 | Gemtesa, Myfembree |
| Agile Therapeutics, INC. | $35.20 | 2021-2022 | |
| Scynexis, INC. | $30.33 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $30.31 | 2019-2020 | |
| Baxter Healthcare | $29.80 | 2021 | |
| Laborie Medical Technologies Corp. | $29.46 | 2020 | |
| Silk Road Medical, INC. | $27.48 | 2020 | |
| Davol INC. | $26.49 | 2022 | |
| Coopersurgical, INC. | $26.07 | 2020-2022 | |
| Hologic Sales and Service, LLC | $23.53 | 2019 | |
| Mayne Pharma Commercial LLC | $20.95 | 2023 | |
| Kci USA, INC. | $17.93 | 2020 | |
| Abbott Laboratories | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Chacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.